abstract |
The present invention relates to the treatment of obesity and related conditions using TGF-β inhibitors. More specifically, the present invention relates to the use of TGF-β inhibitors in the treatment of obesity, type 2 diabetes, and pathological conditions associated with obesity or type 2 diabetes. |